In a groundbreaking discovery, researchers have identified a natural plant compound called sinapic acid as a promising agent for accelerating wound healing in diabetic conditions. This advancement could pave the way for a safe, natural and effective therapy for managing diabetic wounds—a major concern for millions globally suffering from diabetes mellitus. The study was undertaken by Nagaland University, in collaboration with Lovely Professional University (LPU), Punjab.
The findings were published in the peer-reviewed journal Nature Scientific Reports, revealing that oral administration of Sinapic acid enhances wound closure in preclinical diabetic models. Scientists found that the compound stimulates the SIRT1 pathway, a crucial driver of tissue repair, blood vessel formation, and inflammation reduction. The research demonstrated that lower doses (20 mg/kg) were even more effective than higher ones, providing valuable insights for optimal dosing and future therapeutic strategies.
“Our study highlights the strength of our scientific community and our commitment to innovation rooted in nature,” said Prof. Jagadish K. Patnaik, Vice Chancellor of Nagaland University. He praised the team’s contribution to tackling urgent health challenges through this nature-based solution.
Lead researcher Prof. Pranav Kumar Prabhakar, Head of the Department of Biotechnology, School of Engineering and Technology at Nagaland University, added, “Existing synthetic drugs for diabetic wounds have limitations and may cause undesirable side effects. By exploring plant-derived alternatives like Sinapic acid—a natural antioxidant present in many edible plants—we aim to offer an affordable, effective solution, especially for patients in rural or resource-poor settings.”
The study’s real-world implications are significant: the use of Sinapic acid could lower risks of amputation, speed up recovery in diabetic foot ulcers, and make therapies more accessible due to its natural, oral formulation. Moving forward, the researchers plan to conduct molecular pathway studies, ensure safety through toxicity profiling, develop capsule or nutraceutical formulations, and initiate pilot clinical trials to evaluate safety and efficacy in diabetic patients.
This discovery reinforces the importance of interdisciplinary research in driving innovations that address pressing global health challenges and brings hope for a better quality of life for diabetic patients worldwide.
